TY - JOUR
T1 - Lack of association between the MEF2A gene and myocardial infarction
AU - Lieb, Wolfgang
AU - Mayer, Björn
AU - König, Inke R.
AU - Borwitzky, Iris
AU - Götz, Anika
AU - Kain, Silke
AU - Hengstenberg, Christian
AU - Linsel-Nitschke, Patrick
AU - Fischer, Marcus
AU - Döring, Angela
AU - Wichmann, H. Erich
AU - Meitinger, Thomas
AU - Kreutz, Reinhold
AU - Ziegler, Andreas
AU - Schunkert, Heribert
AU - Erdmann, Jeanette
PY - 2008/1/1
Y1 - 2008/1/1
N2 - BACKGROUND - Coronary artery disease (CAD) and myocardial infarction (MI) are caused in part by genetic factors. Recently, the MEF2A gene was linked to MI/CAD in a single pedigree with autosomal-dominant pattern of inheritance. In addition, genetic variants within the gene have been associated with MI in case-control settings, producing inconsistent results. METHODS AND RESULTS - The MEF2A gene was sequenced in MI patients from 23 MI families (≥5 affected members per family), but no mutation was identified in any of these extended families. Moreover, the Pro279Leu variant in exon 7 was analyzed in 1181 unrelated MI patients with a positive family history for MI/CAD, in 533 patients with sporadic MI, and in 2 control populations (n=1021 and n=1055), showing no evidence for association with MI/CAD. In addition, a (CAG)n repeat in exon 11 was genotyped in 543 sporadic MI patients and in 1190 controls without evidence for association with MI. Finally, analyzing 11 single-nucleotide polymorphisms from the GeneChip Mapping 500K Array, genotyped in 1644 controls and 753 cases, failed to provide evidence for association (region-wide P=0.23). CONCLUSIONS - Studying independent samples of >1700 MI patients, 2 large control populations, and multiple families with apparently mendelian inheritance of the disease, we found no evidence for any linkage or association signal in the MEF2A gene.
AB - BACKGROUND - Coronary artery disease (CAD) and myocardial infarction (MI) are caused in part by genetic factors. Recently, the MEF2A gene was linked to MI/CAD in a single pedigree with autosomal-dominant pattern of inheritance. In addition, genetic variants within the gene have been associated with MI in case-control settings, producing inconsistent results. METHODS AND RESULTS - The MEF2A gene was sequenced in MI patients from 23 MI families (≥5 affected members per family), but no mutation was identified in any of these extended families. Moreover, the Pro279Leu variant in exon 7 was analyzed in 1181 unrelated MI patients with a positive family history for MI/CAD, in 533 patients with sporadic MI, and in 2 control populations (n=1021 and n=1055), showing no evidence for association with MI/CAD. In addition, a (CAG)n repeat in exon 11 was genotyped in 543 sporadic MI patients and in 1190 controls without evidence for association with MI. Finally, analyzing 11 single-nucleotide polymorphisms from the GeneChip Mapping 500K Array, genotyped in 1644 controls and 753 cases, failed to provide evidence for association (region-wide P=0.23). CONCLUSIONS - Studying independent samples of >1700 MI patients, 2 large control populations, and multiple families with apparently mendelian inheritance of the disease, we found no evidence for any linkage or association signal in the MEF2A gene.
UR - http://www.scopus.com/inward/record.url?scp=38049144096&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.107.728485
DO - 10.1161/CIRCULATIONAHA.107.728485
M3 - Journal articles
C2 - 18086930
AN - SCOPUS:38049144096
SN - 0009-7322
VL - 117
SP - 185
EP - 191
JO - Circulation
JF - Circulation
IS - 2
ER -